FDA
approval
· 2022-09-28
FDA Approved: ZENPEP — Supplemental Application (Aimmune Therapeutics, Inc.)
Summary
FDA approved a supplemental application for ZENPEP (pancrelipase) submitted by Aimmune Therapeutics, Inc., expanding/adjusting its labeling and indications thro…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZENPEP (PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE)